These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19822654)

  • 1. 12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis.
    Middleton MK; Zukas AM; Rubinstein T; Kinder M; Wilson EH; Zhu P; Blair IA; Hunter CA; Puré E
    Infect Immun; 2009 Dec; 77(12):5690-700. PubMed ID: 19822654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase.
    Middleton MK; Rubinstein T; Puré E
    J Immunol; 2006 Jan; 176(1):265-74. PubMed ID: 16365418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection.
    Aliberti J; Serhan C; Sher A
    J Exp Med; 2002 Nov; 196(9):1253-62. PubMed ID: 12417634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA; Chizzonite R; Remington JS
    J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.
    Caamaño J; Tato C; Cai G; Villegas EN; Speirs K; Craig L; Alexander J; Hunter CA
    J Immunol; 2000 Nov; 165(10):5720-8. PubMed ID: 11067930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.
    Cai G; Radzanowski T; Villegas EN; Kastelein R; Hunter CA
    J Immunol; 2000 Sep; 165(5):2619-27. PubMed ID: 10946290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction.
    Scharton-Kersten T; Contursi C; Masumi A; Sher A; Ozato K
    J Exp Med; 1997 Nov; 186(9):1523-34. PubMed ID: 9348310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of interleukin-2-deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon.
    Villegas EN; Lieberman LA; Carding SR; Hunter CA
    Infect Immun; 2002 Sep; 70(9):4757-61. PubMed ID: 12183516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.
    Wille U; Nishi M; Lieberman L; Wilson EH; Roos DS; Hunter CA
    Parasite Immunol; 2004 May; 26(5):229-36. PubMed ID: 15491472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C5aR1 Activation Drives Early IFN-γ Production to Control Experimental
    Briukhovetska D; Ohm B; Mey FT; Aliberti J; Kleingarn M; Huber-Lang M; Karsten CM; Köhl J
    Front Immunol; 2020; 11():1397. PubMed ID: 32733463
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective role for interleukin-5 during chronic Toxoplasma gondii infection.
    Zhang Y; Denkers EY
    Infect Immun; 1999 Sep; 67(9):4383-92. PubMed ID: 10456878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
    Gazzinelli RT; Wysocka M; Hieny S; Scharton-Kersten T; Cheever A; Kühn R; Müller W; Trinchieri G; Sher A
    J Immunol; 1996 Jul; 157(2):798-805. PubMed ID: 8752931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.
    Scharton-Kersten T; Caspar P; Sher A; Denkers EY
    Exp Parasitol; 1996 Nov; 84(2):102-14. PubMed ID: 8932760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
    Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
    Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha.
    Hunter CA; Subauste CS; Van Cleave VH; Remington JS
    Infect Immun; 1994 Jul; 62(7):2818-24. PubMed ID: 7911785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii.
    Villegas EN; Lieberman LA; Mason N; Blass SL; Zediak VP; Peach R; Horan T; Yoshinaga S; Hunter CA
    J Immunol; 2002 Jul; 169(2):937-43. PubMed ID: 12097399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
    Scharton-Kersten TM; Wynn TA; Denkers EY; Bala S; Grunvald E; Hieny S; Gazzinelli RT; Sher A
    J Immunol; 1996 Nov; 157(9):4045-54. PubMed ID: 8892638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice.
    Guiton R; Vasseur V; Charron S; Arias MT; Van Langendonck N; Buzoni-Gatel D; Ryffel B; Dimier-Poisson I
    J Infect Dis; 2010 Aug; 202(3):427-35. PubMed ID: 20575661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.
    Johnson LL; Sayles PC
    Infect Immun; 2002 Jan; 70(1):185-91. PubMed ID: 11748181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.